Journal article
Clinical and Biomarker Determinants for Recurrent Stroke in Patients With Atrial Fibrillation
Abstract
BACKGROUND AND OBJECTIVES: Despite effective secondary prevention, including oral anticoagulant (OAC) therapy, the risk of recurrent stroke (RS) in patients with atrial fibrillation (AF) remains substantial with an annualized risk of 3.2%-6.5% per year. The reasons for this high residual risk are unclear. There is growing need for improved risk prediction tools to identify patients at greatest risk of RS in AF and to find new therapeutic …
Authors
Cheung Y; Foley M; Bradley D; Cassidy T; Collins R; Cronin S; Dolan E; Gorey S; Khadjooi K; Induruwa I
Journal
Neurology, Vol. 104, No. 1,
Publisher
Wolters Kluwer
Publication Date
January 14, 2025
DOI
10.1212/wnl.0000000000210061
ISSN
0028-3878